Renal denervation for heart failure with preserved heart strength
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether a procedure that calms overactive kidney nerves (renal denervation) can improve symptoms and heart function in people with heart failure with preserved ejection fraction. It also checks that the kidney arteries are suitable and that your blood pressure and heart pressure measurements meet the study targets.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure (on stable meds for at least 4 weeks) and recent 24-hour BP readings in the study range
- You have heart failure with preserved ejection fraction, including a blood marker (NT-proBNP) and an ultrasound heart function measure (ejection fraction 55% or higher)
- Your heart failure symptoms are in NYHA class II or III (mild to more limiting symptoms)
- A heart catheter test shows high filling pressures at rest or with exercise
- Your age is 18 to 80, and you can sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether renal denervation (a procedure to reduce overactive signals in kidney arteries) can help people who have heart failure but keep a normal pumping ability and still have high blood pressure. It aims to improve blood-pressure control and heart function in this specific group.
This trial tests a procedure called renal denervation (using radio waves to calm overactive nerves in the kidney) to see if it helps lower blood pressure in people on dialysis who have resistant high blood pressure.
This trial tests whether a minimally invasive procedure called renal denervation—which reduces nerve activity in blood vessels near the kidneys—can help people with heart failure feel better and exercise with less shortness of breath. You would receive this procedure in addition to your regular heart failure medications.
This trial tests a procedure called renal denervation—which reduces nerve signals to the kidneys—to help control high blood pressure in patients who are having staged heart procedures to open blocked coronary arteries. The goal is to see if this approach helps patients whose blood pressure remains high even on multiple blood pressure medications.
This trial tests a procedure called renal denervation (using radiofrequency energy to calm overactive kidney nerves) in people who have chest pain caused by tiny heart artery dysfunction and also have hard-to-control high blood pressure. The goal is to see if treating the kidney nerves improves blood flow in the small heart arteries.
This trial tests a procedure called renal denervation for people with untreated high diastolic blood pressure. The procedure uses a small catheter to interrupt nerve signals around the kidneys, which may help lower blood pressure.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.